Therakos CELLEX Photopheresis System
FDA premarket approval P860003/S090 · decided 2017-07-21
Approval details
- PMA number
- P860003
- Supplement
- S090
- Supplement type
- Real-Time Process
- Supplement reason
- Change Design/Components/Specifications/Material
- Trade name
- Therakos CELLEX Photopheresis System
- Generic name
- System, photopheresis, extracorporeal
- Applicant
- Therakos Development Limited
- Date received
- 2017-05-22
- Decision date
- 2017-07-21
- Days to decision
- 60 days
- Decision code
- APPR
- Product code
- LNR
- Advisory committee
- Gastroenterology, Urology
- Expedited review
- No
- Location
- Dublin
- Statement
- Approval for a design change to replace the 24 V power supply in the device.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.